Sector portfolio · VC firm · United States

Samsara BioCapital's Pharma portfolio

Samsara BioCapital has backed 16 Pharma startups in rounds we track, $2.6B between them, shown by the stage each has reached. The best-funded is Mineralys Therapeutics.

16startups backed
3stages
$2.6Braised between them
Series Bbiggest stage

Samsara BioCapital's profile

Series B

7

Stage not reported

7

Series C and later

2

Segment by segment

Series B

7 startups · $758M raised

  1. AllakosAllakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.United States$294M
  2. Claris BiotherapeuticsClaris Biotherapeutics is a late-clinical stage biotechnology company based in Jersey City, New Jersey.United States$124M
  3. Pathalys PharmaPathalys Pharma is a private biopharmaceutical company based in Raleigh, North Carolina, founded in 2021.United States$105M
  4. OrsoBioOrsoBio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for severe metabolic disorders, iUnited States$67M
  5. Rain OncologyRain Oncology is a clinical-stage company focusing on research and development of innovative therapies for cancer patients.-$63M
  6. AttralusAttralus is a clinical-stage biopharmaceutical company focused on developing innovative medicines and diagnostics for systemic amyloidosis.United States$56M
  7. Enara BioEnara Bio Limited, based in Oxford, United Kingdom, is a biotechnology company focused on developing innovative cancer immunotherapies.United Kingdom$49M

Stage not reported

7 startups · $1.4B raised

  1. Mineralys TherapeuticsMineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.United States$788M
  2. Jade BiosciencesJade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.United States$195M
  3. Inventiva PharmaInventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.France$120M
  4. HilleVaxHilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.United States$100M
  5. Mereo BiopharmaMereo is a new UK-based speciality biopharmaceutical company.United Kingdom$92M
  6. Elevation OncologyElevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.United States$50M
  7. Enlaza TherapeuticsEnlaza Therapeutics is a biotechnology company based in La Jolla, California, focused on developing covalent protein biologics forUnited States$15M

Series C and later

2 startups · $467M raised

  1. ACELYRINACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.United States$300M
  2. Scholar RockScholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.United States$167M

How this map is made. Every startup here works in Pharma and has raised money in a round we track that names Samsara BioCapital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioSamsara BioCapital's Biotech portfolio62 startups · $11BCo-investorsWho invests with Samsara BioCapital68 co-investorsSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426BSector portfolioGeneral Catalyst's AI portfolio226 startups · $179B

Raising from investors like Samsara BioCapital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps